Luis Corchete
Overview
Explore the profile of Luis Corchete including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muntion S, Preciado S, Sanchez-Luis E, Corchete L, Diez-Campelo M, Osugui L, et al.
Ther Adv Hematol
. 2023 Jan;
13:20406207221142137.
PMID: 36601635
Background: Eltrombopag (EP) is a small molecule that acts directly on hematopoietic stem cells (HSCs) and megakaryocytes to stimulate the hematopoietic process. Mesenchymal stem/stromal cells (MSCs) are key hematopoietic niche...
2.
Okada Y, Peng F, Perea J, Corchete L, Bujanda L, Li W, et al.
Br J Cancer
. 2022 Nov;
128(1):112-120.
PMID: 36319845
Background: There are no robust tools for the diagnosis of synchronous colorectal cancer (SyCRC). Herein, we developed the first methylation signature to identify and characterise patients with SyCRC. Methods: For...
3.
Perea J, Corchete L, Garcia J, Urioste M, Gonzalez-Sarmiento R
Front Mol Biosci
. 2022 Feb;
8:803707.
PMID: 35127822
No abstract available.
4.
Perea J, Garcia J, Corchete L, Tapial S, Olmedillas-Lopez S, Vivas A, et al.
Sci Rep
. 2021 Jan;
11(1):2202.
PMID: 33500439
Rectal cancer (RC) appears to behave differently compared with colon cancer. We aimed to analyze existence of different subtypes of RC depending on distinct features (age of onset and the...
5.
Tapial S, Garcia J, Corchete L, Holowatyj A, Perez J, Rueda D, et al.
Eur J Hum Genet
. 2020 Dec;
29(4):709-713.
PMID: 33268847
Copy neutral loss of heterozygosity (cnLOH) is a common event in several human malignancies-positing this as a mechanism of carcinogenesis. However, the role of cnLOH in synchronous colorectal cancer (SCRC),...
6.
Perea J, Garcia J, Corchete L, Lumbreras E, Arriba M, Rueda D, et al.
Int J Cancer
. 2018 Aug;
144(7):1596-1608.
PMID: 30151896
To analyze the possible clonal origin of a part of Synchronous colorectal cancer (SCRC), we studied 104 paired-SCRCs from 52 consecutive patients without hereditary forms of CRC. We used a...
7.
Gutierrez M, Corchete L, Teodosio C, Sarasquete M, Abad M, Iglesias M, et al.
Oncotarget
. 2015 Jun;
6(22):19070-86.
PMID: 26053098
Significant advances have been achieved in recent years in the identification of the genetic and the molecular alterations of pancreatic ductal adenocarcinoma (PDAC). Despite this, at present the understanding of...
8.
Gutierrez M, Munoz-Bellvis L, Sarasquete M, Hernandez-Mejia D, Abad M, Bengoechea O, et al.
J Mol Diagn
. 2014 Aug;
16(6):648-59.
PMID: 25157969
Most patients with pancreatic ductal adenocarcinoma (PDAC) die within 6 months of diagnosis. However, 20% to 25% patients undergoing total tumor resection remain alive and disease-free 5 years after diagnostic...
9.
Paiva B, Paino T, Sayagues J, Garayoa M, San-Segundo L, Martin M, et al.
Blood
. 2013 Sep;
122(22):3591-8.
PMID: 24072855
Circulating myeloma tumor cells (CTCs) as defined by the presence of peripheral blood (PB) clonal plasma cells (PCs) are a powerful prognostic marker in multiple myeloma (MM). However, the biological...